Evidence map›Paper›PMID 25092988›Full record

ArticleOncoTargets and therapy2014

High expression of HEF1 is associated with poor prognosis in urinary bladder carcinoma.

Qi Zhang, Hui-Ju Wang, Da-Hong Zhang, Guo-Qing Ru, Xu-Jun He, Ying-Yu Ma

Open access · goldAbstract read
In one paragraph

Article in OncoTargets and therapy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Focal adhesion kinase (FAK) is associated with poor prognosis in urinary bladder carcinoma.International journal of clinical and experimental pathology · 2018
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Qi ZhangDepartment of Urology, Zhejiang Provincial People's Hospital, Hangzhou, People's Republic of China.
Hui-Ju WangKey Laboratory of Gastroenterology of Zhejiang Province, Zhejiang Provincial People's Hospital, People's Republic of China.
Da-Hong ZhangDepartment of Urology, Zhejiang Provincial People's Hospital, Hangzhou, People's Republic of China.
Guo-Qing RuDepartment of Pathology, Zhejiang Provincial People's Hospital, Hangzhou, People's Republic of China.
Xu-Jun HeKey Laboratory of Gastroenterology of Zhejiang Province, Zhejiang Provincial People's Hospital, People's Republic of China.
Ying-Yu MaKey Laboratory of Gastroenterology of Zhejiang Province, Zhejiang Provincial People's Hospital, People's Republic of China.
Zhejiang Provincial People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human enhancer of filamentation 1 (HEF1) is a multidomain scaffolding protein that has been thought to play an important role in the tumor progression of various cancers. HEF1 expression has not previously been reported in urinary bladder carcinoma, and little is known about its prognostic significance. The aim of this study was to evaluate the expression patterns of HEF1 in urinary bladder carcinoma and to investigate its prognostic significance. HEF1 expression was analyzed by immunohistochemistry using tissue microarray. A significant relationship between HEF1 expression and sex, tumor size, number of tumors, invasion depth, lymph node metastasis, and distant metastasis was found, and high expression of HEF1 was associated with worse overall survival when compared to low expression of HEF1. Multivariate analysis showed that HEF1 expression was an independent prognostic factor for overall survival in urinary bladder carcinoma. We investigated HEF1 expression in urinary bladder carcinoma and found that high HEF1 expression was associated with advanced stage, large tumor size, and shortened progression-free survival. Although the biologic function of HEF1 in urinary bladder carcinoma remains unknown, the expression of HEF1 can provide new prognostic information for disease progression.

Indexed as

bladder cancerhuman enhancer of filamentation 1immunohistochemistrymetastasisprogression-free survival

Identifiers

PMID25092988
PMCPMC4114921
OpenAlexW2015678691

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.